New CMS Phase 2 Guidelines

By Ben Carmel
Manufacturers Finally Receive Long Awaited Phase 2 Reporting Guidelines from CMS Providing Limited Data Testing Options Phase 2 Open Payments submission guidelines and timelines were issued last week by CMS Read more

Transparency in Europe

By Marc Eigner
A key issue faced by the European life sciences compliance community that clearly came to the fore at this year’s CBI Global Transparency Congress held in London was the battle Read more